Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhongfeng Huichun Pian for recovery-phase acute ischemic stroke
ChiCTR2400083136Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zhongfeng huichun pian in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Fugl-Meyer scale score. Started Apr 2024; status: recruiting.
02
Drugs
zhongfeng huichun pian
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400083136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083136.